Quantcast
 
New book by Larry Connors - Click here to read more

Quote

Receive Alerts Free
For One Week!


Short Term PowerRatings
Use PowerRatings every day to find the stocks for tomorrow to focus on and the ones to avoid.
Sign Up Now >>

Long Term PowerRatings
Use PowerRatings to find the stocks to focus on to build your portfolio for long-term gains.
Sign Up Now >>

Gary Kaltbaum Intraday Breaking Setups
Let Gary Kaltbaum send you timely emails to alert you when breakouts occur.
Sign Up Now >>

Kevin Haggerty's Professional Trading Service
Every day receive the best plan of attack for the next day's trading directly from professional trader Kevin Haggerty.
Sign Up Now >>



PowerRatings Across The Indexes: PG, JNJ, PAYX, AMGN, MDT, BAX

By David Goodboy | TradingMarkets.com
Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS

Yesterday, we experienced the largest one day point gain of all time in the major stock indexes. Massive government intervention appears to lifting the world's economic system out of its downward spiral. However, no one really knows what is going to happen in the market next.

Long term investors need a tool to build a portfolio of the stocks most likely suited for gains over the next year. Twelve years of extensive, statistically valid studies have proven our long term PowerRatings to be exactly what long term investors need to evaluate and choose stocks for their portfolios. The proprietary calculating engine behind the PowerRatings is constantly scanning the universe of stocks ranking them in a 1 to 10 rating system.

Our studies have clearly proven that stocks with a 9 long term PowerRating have a 79.1 % chance of being higher one year later. Those that earned a 10 rating possess an 81% chance of being higher one year later. Eight rated stocks are also likely to outperform their brethren over a year time frame. Stocks rated 4, 5, 6, 7 have proven to simply perform with the market. The low rated 1, 2 and 3 ranked stocks have proven to be too volatile thus risky for prudent long term investment. Although, sometimes these jumpy stocks can produce stellar returns, our studies have proven that they are far too dangerous for conservative, long term investment. Let's take a closer look at several top ranked stocks across the 3 major indexes.

The DJIA

Proctor & Gamble (PG | Quote | Chart | News | PowerRating) - This giant personal products company is the third ranked member of the Dow Jones Industrial Average. They earned a 7 long term PowerRating as the stock has just bounced off of the 55 range on the chart, and it appears that the uptrend may be restored. They have recently confirmed earnings projections of 8 to 10% growth.

PG PowerRatings Chart

Johnson & Johnson (JNJ | Quote | Chart | News | PowerRating) - The number one rated stock from the Dow 30 Index with an 8 long term PowerRating. The New Brunswick, NJ based drug manufacturer posted an 8.7% increase in sales and a 12.4% increase in earnings per share for the 2nd quarter. Technically, market conditions appear to have knocked this stock down to the 52 level where it has found a base, bouncing back up hard.

JNJ PowerRatings Chart

The Nasdaq

Paychex (PAYX | Quote | Chart | News | PowerRating) - Has earned a 5 rating. Price has bounced off of a low near 26. It has recently announced an increase in earnings, revenues, and income making this 5 rated stock one that should be watched closely for upgrades.

PAYX PowerRatings Chart

Amgen Inc (AMGN | Quote | Chart | News | PowerRating) - This venerable biotechnology company is the second highest ranked stock in the Nasdaq. It has earned a 7 long term PowerRatings. Earnings have increased by 2% , revenue by 1% and full year revenue guidance was raised from $14.2 billion to $14.6-14.9 billion. The CEO stated that the first 6 months of 2008 showed stability and they are very pleased with the outcome of various tests on new drug products. Technically, price is bouncing off the 45 level that appears to be support.

AMGN PowerRatings Chart

The S&P 500

Medtronics (MDT | Quote | Chart | News | PowerRating) - This medical equipment maker earned an 8 long term PowerRating. It is the fourth highest ranked stock in the index. They recently announced that first quarter revenue was up 19%. Technically, the stock was knocked down a bit, but appears to be in the process of recovery.

MDT PowerRatings Chart

Baxter International (BAX | Quote | Chart | News | PowerRating) - A medical equipment and supply company that has earned an 8 long term PowerRating. They recently posted a 31% second quarter earnings per share increase and have raised their full year guidance. Technically, the company appears to have hit a bottom around 52 and has bounced up from this level.

BAX PowerRatings Chart

Click here to start your free, 7-day trial to our Short Term PowerRatings!

Learn what you need to know as an active investor looking to invest in companies with a history of financial strength and a track record for growth. Click the link above or call us at 888-484-8220 extension 1 to get your copy of the "5 Secrets to Successful Stock Investing" today!

David Goodboy is Vice President of Marketing for a New York City based multi-strategy fund.


>> See more articles by David Goodboy
Stocks RSS
Related Articles
More Related Articles >>
PREMIER SPONSORED LINKS
TRADE CENTER
 
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.